Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Park Aerospace
PKE
$737M
| $524K | ﹤0.01% |
25,740
-5,849
| -19% | -$106K |
|
3727
ADC Therapeutics
ADCT
$134M
| $522K | ﹤0.01% |
130,460
-14,947
| -10% | -$47.1K |
|
3728
Farmers & Merchants Bancorp
FMAO
$459M
| $521K | ﹤0.01% |
20,840
-1,596
| -7% | -$41.1K |
|
3729
Atlanticus Holdings
ATLC
$1.59B
| $521K | ﹤0.01% |
8,895
-2,302
| -21% | -$139K |
|
3730
Home Bancorp
HBCP
$561M
| $521K | ﹤0.01% |
9,583
-1,743
| -15% | -$95.5K |
|
3731
Accuray
ARAY
$32M
| $520K | ﹤0.01% |
311,614
-34,653
| -10% | -$51.3K |
|
3732
PUT
Sable Offshore Corp
SOC
$1.01B
| $520K | ﹤0.01% |
29,800
-70,200
| -70% | -$1.8M |
|
3733
Forrester Research
FORR
$223M
| $520K | ﹤0.01% |
49,059
+3,280
| +7% | +$33.2K |
|
|
SION
3734
Sionna Therapeutics
SION
$2.13B
| $519K | ﹤0.01% |
17,643
-5,379
| -23% | -$117K |
|
3735
Citizens & Northern Corp
CZNC
$456M
| $518K | ﹤0.01% |
26,173
+510
| +2% | +$10K |
|
3736
B&G Foods
BGS
$287M
| $518K | ﹤0.01% |
117,009
-28,189
| -19% | -$123K |
|
3737
AtaiBeckley Inc
ATAI
$2.66B
| $516K | ﹤0.01% |
97,538
-67,349
| -41% | -$273K |
|
3738
Mesa Laboratories
MLAB
$564M
| $513K | ﹤0.01% |
7,663
-2,507
| -25% | -$180K |
|
3739
Franklin Financial Services
FRAF
$284M
| $513K | ﹤0.01% |
11,157
+3,692
| +49% | +$159K |
|
3740
Riley Exploration Permian
REPX
$744M
| $513K | ﹤0.01% |
18,929
-5,241
| -22% | -$143K |
|
3741
Pacific Biosciences
PACB
$435M
| $512K | ﹤0.01% |
399,907
-90,185
| -18% | -$122K |
|
3742
Invesco KBW Bank ETF
KBWB
$6.84B
| $510K | ﹤0.01% |
+6,518
| New | +$491K |
|
|
XOMA
3743
DELISTED
Xoma
XOMA
| $510K | ﹤0.01% |
13,224
-3,416
| -21% | -$106K |
|
|
ZBIO
3744
Zenas BioPharma
ZBIO
$1.98B
| $508K | ﹤0.01% |
22,876
-4,937
| -18% | -$80.4K |
|
|
NUTX
3745
Nutex Health
NUTX
$1.01B
| $507K | ﹤0.01% |
4,908
-1,770
| -27% | -$174K |
|
3746
Itaú Unibanco
ITUB
$93.2B
| $507K | ﹤0.01% |
71,111
+18,059
| +34% | +$119K |
|
3747
Agilon Health
AGL
$1.53B
| $506K | ﹤0.01% |
19,645
-7,162
| -27% | -$271K |
|
3748
TIM SA
TIMB
$9.16B
| $506K | ﹤0.01% |
22,648
+5,953
| +36% | +$120K |
|
3749
Security National Financial
SNFCA
$244M
| $505K | ﹤0.01% |
61,194
-6,402
| -9% | -$54K |
|
3750
Mayville Engineering Co
MEC
$654M
| $505K | ﹤0.01% |
36,677
-3,825
| -9% | -$57.5K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.